anti-angiogenic peptide (Eyebio Korea)

N/A

Report date: 2025/01/26 19:19:26

Base Information

Drug Nameanti-angiogenic peptide (Eyebio Korea)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionAngiogenesis inhibitors
TargetsUpdating
Therapy Area/IndicationsRetinopathy of PrematurityWet age-related macular degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEyebioKorea Inc
China Registration ClassN/A

Develop Information

Active CompaniesEyebioKorea Inc
Inactive CompaniesN/A
Active IndicationsRetinopathy of PrematurityWet age-related macular degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A